Frankfurt - Delayed Quote EUR
Corcept Therapeutics Incorporated (HTD.F)
68.78
+1.18
+(1.75%)
At close: May 30 at 9:48:34 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | Sale | May 2, 2025 | -- |
| GUYER WILLIAM Officer | Sale | May 16, 2025 | 5,487 |
| HUNT HAZEL Officer | Conversion of Exercise of derivative security | Feb 11, 2025 | 183,405 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale | May 1, 2025 | 9,009 |
| MADUCK SEAN Officer | Sale | May 2, 2025 | 105,622 |
| MAHONEY DAVID L Director | Sale | May 16, 2025 | 1,258,760 |
| MOKARI ATABAK Chief Financial Officer | Stock Award(Grant) | Mar 3, 2025 | 13,034 |
| ROBB GARY CHARLES Officer | Sale | May 20, 2025 | 26,777 |
| SWISHER DANIEL N JR Director | Sale | May 12, 2025 | 0 |
| WILSON JAMES N Director | Stock Gift | Jan 27, 2025 | -- |